Related News
Seeking global strategy
July 24, 2011, Sunday
|
Print Edition
Print Edition
THE first official WHO-supported World Hepatitis Day falls on coming Thursday, and activists and advocates are pressing for a global strategy to combat the infectious disease that's endemic in China.
According to the World Health Organization, around 2 billion people worldwide are infected and 350 million live with chronic infection. An estimated 600,000 people die each year due to the acute or chronic consequences of hepatitis B.
Because of its huge population, China has the highest number of both acutely and chronically infected people.
In China, there are around 93 million cases - including 20 million chronic cases. Around 280,000 people die every year of related cirrhosis and liver cancer.
China has made great efforts to control the disease, including vaccinating all newborns since 2002 and expanding vaccination coverage to people born between 1994 and 2002.
Non-governmental organizations have helped build a bridge between patients and the government, according to Wang Zhao, director of the Wu Jieping Medical Foundation, an NGO. They carry out research, education and advocacy.
Vaccination of newborns was first undertaken on a small scale with vaccines donated to the foundation, then expanded nationwide.
NGOs are also expected to search for innovative ways in which they can help improve the lives of hepatitis patients, according to John Damonti, president of Bristol-Myers Squibb Foundation, which has been working on hepatitis problems in China since 2002.
According to the World Health Organization, around 2 billion people worldwide are infected and 350 million live with chronic infection. An estimated 600,000 people die each year due to the acute or chronic consequences of hepatitis B.
Because of its huge population, China has the highest number of both acutely and chronically infected people.
In China, there are around 93 million cases - including 20 million chronic cases. Around 280,000 people die every year of related cirrhosis and liver cancer.
China has made great efforts to control the disease, including vaccinating all newborns since 2002 and expanding vaccination coverage to people born between 1994 and 2002.
Non-governmental organizations have helped build a bridge between patients and the government, according to Wang Zhao, director of the Wu Jieping Medical Foundation, an NGO. They carry out research, education and advocacy.
Vaccination of newborns was first undertaken on a small scale with vaccines donated to the foundation, then expanded nationwide.
NGOs are also expected to search for innovative ways in which they can help improve the lives of hepatitis patients, according to John Damonti, president of Bristol-Myers Squibb Foundation, which has been working on hepatitis problems in China since 2002.
- About Us
- |
- Terms of Use
- |
-
RSS - |
- Privacy Policy
- |
- Contact Us
- |
- Shanghai Call Center: 962288
- |
- Tip-off hotline: 52920043
- 娌狪CP璇侊細娌狪CP澶05050403鍙-1
- |
- 浜掕仈缃戞柊闂讳俊鎭湇鍔¤鍙瘉锛31120180004
- |
- 缃戠粶瑙嗗惉璁稿彲璇侊細0909346
- |
- 骞挎挱鐢佃鑺傜洰鍒朵綔璁稿彲璇侊細娌瓧绗354鍙
- |
- 澧炲肩數淇′笟鍔＄粡钀ヨ鍙瘉锛氭勃B2-20120012
Copyright 漏 1999- Shanghai Daily. All rights reserved.Preferably viewed with Internet Explorer 8 or newer browsers.
